Kaori Karimata

Low-dose dasatinib in older patients with chronic myeloid leukaemia in chronic phase (DAVLEC): a single-arm, multicentre, phase 2 trial

Kazunori Murai, Hiroshi Ureshino, Takashi Kumagai et al. · The Lancet Haematology · 2021 · 64 citations

Medicine, Hematology, Pharmacology +8

Proteomic profiling of HTLV-1 carriers and ATL patients reveals sTNFR2 as a novel diagnostic biomarker for acute ATL

Carmina Louise Hugo Guerrero, Yoshiko Yamashita, Megumi Miyara et al. · Blood Advances · 2020 · 28 citations · Full text

Medicine, Hematology, Oncology +16

Myelodysplastic Syndrome with Ph Negative Monosomy 7 Chromosome following Transient Bone Marrow Dysplasia during Imatinib Treatment for Chronic Myeloid Leukemia

Kaori Karimata, Masayoshi Masuko, Takashi Ushiki et al. · Internal Medicine · 2011 · 17 citations · Full text

Medicine, Hematology, Oncology +17

Pharmacokinetic and pharmacodynamic analysis of cyclosporine A (CsA) to find the best single time point for the monitoring and adjusting of CsA dose using twice-daily 3-h intravenous infusions in allogeneic hematopoietic stem cell transplantation

Tatsuo Furukawa, Tori Kurasaki-Ida, Masayoshi Masuko et al. · International Journal of Hematology · 2010 · 13 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Characterization of patients with aggressive adult T-cell leukemia–lymphoma in Okinawa, Japan: a retrospective analysis of a large cohort

Yukiko Nishi, Takuya Fukushima, Shogo Nomura et al. · International Journal of Hematology · 2016 · 10 citations

Medicine, Hematology, Oncology +13